PACB

Pacific Biosciences of California, Inc.

1.37

USD

-0.01

-0.72%

Sep 18, 15:31 UTC -4

Closed

After-Market

1.35

-0.02

-1.09%

PACB Earnings Reports

Positive Surprise Ratio

PACB beat 21 of 42 last estimates.

50%

Next Report

Date of Next Report

Nov 03, 2026

Estimate for Q3 26 (Revenue/ EPS)

$41.21M

-$0.15

Implied change from Q2 26 (Revenue/ EPS)

+5.66%

+7.14%

Implied change from Q3 25 (Revenue/ EPS)

+7.21%

+15.38%

Pacific Biosciences of California, Inc. earnings per share and revenue

On Aug 05, 2026, PACB reported earnings of -0.14 USD per share (EPS) for Q2 26, missing the estimate of -0.12 USD, resulting in a -7.94% surprise. Revenue reached 39.01 million, compared to an expected 40.87 million, with a -4.55% difference. The market reacted with a -10.38% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 41.21 million USD, implying an increase of 7.14% EPS, and increase of 5.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

NANO-X IMAGING LTD Ordinary Shares

Report Date

Sep 09, 2026 For Q2 26

Estimate

-$0.16

Actual

-$0.80

Surprise

-380.19%

FAQ

What were Pacific Biosciences of California, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Pacific Biosciences of California, Inc. reported EPS of -$0.14, missing estimates by -7.94%, and revenue of $39.01M, -4.55% below expectations.

How did the market react to Pacific Biosciences of California, Inc.'s Q2 2026 earnings?

The stock price moved down -10.38%, changed from $1.30 before the earnings release to $1.17 the day after.

When is Pacific Biosciences of California, Inc. expected to report next?

The next earning report is scheduled for Nov 03, 2026.

What are the forecasts for Pacific Biosciences of California, Inc.'s next earnings report?

Based on 10 analysts, Pacific Biosciences of California, Inc. is expected to report EPS of -$0.15 and revenue of $41.21M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.